000 04335nam a22006015i 4500
001 978-3-031-54196-4
003 DE-He213
005 20251030113032.0
007 cr nn 008mamaa
008 240829s2024 sz | s |||| 0|eng d
020 _a9783031541964
_9978-3-031-54196-4
024 7 _a10.1007/978-3-031-54196-4
_2doi
050 4 _aR895-920
072 7 _aMMN
_2bicssc
072 7 _aMED080000
_2bisacsh
072 7 _aMKR
_2thema
245 1 0 _aRadiopharmaceuticals
_h[electronic resource] :
_bA Guide to PET/CT and PET/MRI /
_cedited by Ferdinando Calabria, Orazio Schillaci.
250 _a3rd ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aX, 330 p. 232 illus., 216 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1. 18F-FDG -- 2. 18F-DOPA -- 3. The lipogenesis pathway: radiolabeled Choline -- 4. 18F-FET -- 5. 18F-NaF -- 6. Somatostatin receptor analogs (68Ga-DOTATOC, 68Ga-DOTANOC, 68Ga-DOTATATE) -- 7. 7 64Cu-Radiopharmaceuticals -- 8. Amyloid Imaging -- 9. PET myocardial perfusion imaging: 82Rb -- 10. The Bone Pathway: 223Ra-Dichloride -- 11. 11C-Methionine -- 12. 68Ga-PSMA -- 13. PET biomarkers for Tau Pathology -- 14. 18F-Fluciclovine -- 15. 18F-FAPI -- 16. 18F-FES -- 17. 68Ga-Pentixafor -- 18. 18F-FLT -- 19. Neuroinflammation -- 20. 18F-FAZA.
520 _aThe book is a practical and concise guide to PET tracers actually useful for PET/CT and PET/MR imaging. Gaining knowledge on radiopharmaceuticals is often difficult, since their features can be only found in single original journal articles.This book aims to present to the reader, in one single place, clinical features, indications and future trends for PET imaging with a large amount of tracers. While 18F-FDG still remains the miliar stone across PET tracer, new emerging fields of application of PET imaging are consolidated by using disease specific tracers in specific clinical settings. Each chapter is focused on a single tracer or on a group of similar tracers. The basis and structure of the chapters is the same throughout the book: essential information on synthesis and in vivo distribution of a tracer, clinical cases, eloquently showing clinical indications and usefulness, future trends, scientific literature. Featuring over 30 radiopharmaceuticals and 240 clinical cases, the 3rd edition has been enriched with additional chapters on the clinical indications and/or common pitfalls for 18F-fluciclovine PET/CT in prostate cancer imaging and for 18F-MISO in PET tumor hypoxia imaging, as well as applications and future directions for 18F-FES and other PET radiopharmaceuticals. All other chapters of the previous edition have been revised and updated, in particular those chapters covering 18F-DOPA, radiolabeled choline, and 18F-NAF, due to emerging clinical applications for these tracers, 18F-choline for imaging of parathyroid adenoma and 18F-DOPA for restaging of medullary thyroid cancer. The book will be an invaluable guide for professionals and residents in nuclear medicine, radiology, oncology. .
650 0 _aNuclear medicine.
650 0 _aRadiology.
650 0 _aOncology.
_970760
650 0 _aUrology.
_969549
650 0 _aHematology.
_976927
650 0 _aNeurology .
_966816
650 1 4 _aNuclear Medicine.
650 2 4 _aRadiology.
650 2 4 _aOncology.
_970760
650 2 4 _aUrology.
_969549
650 2 4 _aHematology.
_976927
650 2 4 _aNeurology.
_966816
700 1 _aCalabria, Ferdinando.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_983989
700 1 _aSchillaci, Orazio.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_983990
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031541957
776 0 8 _iPrinted edition:
_z9783031541971
776 0 8 _iPrinted edition:
_z9783031541988
856 4 0 _uhttps://doi.org/10.1007/978-3-031-54196-4
912 _aZDB-2-SME
912 _aZDB-2-SXM
999 _c63231
_d63231